Alzheimers Parkinsons ALS

394 bookmarks
Newest
Pediococcus acidilactici KCTC 15831BP-fermented hempseed supplementation corrects metabolite and gut microbiota dysbiosis, potentially mitigating Alzheimer's disease-like symptoms induced by obesity in high-fat diet-fed mice - Food & Function (RSC Publishing)
Pediococcus acidilactici KCTC 15831BP-fermented hempseed supplementation corrects metabolite and gut microbiota dysbiosis, potentially mitigating Alzheimer's disease-like symptoms induced by obesity in high-fat diet-fed mice - Food & Function (RSC Publishing)
A long-term high-fat diet (HFD) causes obesity, disrupting gut microbiota and body metabolite balance, increasing the risk of Alzheimer's disease (AD). Fermented hempseed may restore microbiota balance, improve metabolism, and reduce neuroinflammation, potentially protecting against cognitive decline. This s
·pubs.rsc.org·
Pediococcus acidilactici KCTC 15831BP-fermented hempseed supplementation corrects metabolite and gut microbiota dysbiosis, potentially mitigating Alzheimer's disease-like symptoms induced by obesity in high-fat diet-fed mice - Food & Function (RSC Publishing)
Emergence of taurine as a therapeutic agent for neurological disorders - PMC
Emergence of taurine as a therapeutic agent for neurological disorders - PMC
Taurine is a sulfur-containing, semi-essential amino acid that occurs naturally in the body. It alternates between inflammation and oxidative stress-mediated injury in various disease models. As part of its limiting functions, taurine also modulates ...
·pmc.ncbi.nlm.nih.gov·
Emergence of taurine as a therapeutic agent for neurological disorders - PMC
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in
·x.com·
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Gut microbiome alterations are linked to various diseases, including neurodegeneration, but their ecological and functional impacts remain unclear. Using integrated multi-omics (metagenomics and metatranscriptomics), we analyse microbiome gene co-expression networks in Parkinson's disease (PD) and h …
·pubmed.ncbi.nlm.nih.gov·
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Researchers are increasingly focusing on understanding the microbiota’s influence on disease susceptibility and overall health. The vast number of microorganisms in our gastrointestinal tract and their extensive surface area underscore their ...
·pmc.ncbi.nlm.nih.gov·
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
The biomarkers of Parkinson’s disease (PD) remain to be investigated. This work aimed to identify blood biomarkers for PD using targeted metabolomics analysis. We quantified the plasma levels of 255 metabolites in 92 PD patients and 60 healthy ...
·pmc.ncbi.nlm.nih.gov·
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
Treating Parkinson's Disease with Diet
Treating Parkinson's Disease with Diet
Plant-based diets in general, and certain plant foods in particular, may be used to treat Parkinson's disease—in part, by boosting L-DOPA levels.
·nutritionfacts.org·
Treating Parkinson's Disease with Diet
OptoCeutics | EVY
OptoCeutics | EVY
Find light in the darkness of Alzheimer's and Dementia. Feel better in 5 weeks or get fully reimbursed. See how EVY LIGHT® could help you!
·optoceutics.com·
OptoCeutics | EVY
Is Parkinson's one disease or many?
Is Parkinson's one disease or many?
Share This Sign up at: ParkinsonsDisease.blog About Jonathan Sackner-Bernstein, MD Dr. Sackner-Bernstein shares his pursuit of conquering Parkinson's, using expertise developed as Columbia University faculty, FDA senior official, DARPA insider and witness to the toll of PD. Dr. S-B’s Linkedin page RightBrainBio, Inc. was incorporated in 2022 to develop tranformative therapies for people with Parkinson's.
·parkinsonsdisease.blog·
Is Parkinson's one disease or many?
Treating Parkinson's Disease with Diet - YouTube
Treating Parkinson's Disease with Diet - YouTube
Plant-based diets in general and certain plant foods in particular may be used to successfully treat Parkinson's disease in part by boosting L-DOPA levels. W...
·youtube.com·
Treating Parkinson's Disease with Diet - YouTube